News

Ask Alzheimer's Patient Caregiver: Patch or Pill Therapy?

Publish date: April 6, 2012

 

EXPERT ANALYSIS FROM A PSYCHOPHARMACOLOGY CONFERENCE SPONSORED BY THE NEVADA PSYCHIATRIC ASSOCIATION

Dr. Cummings disclosed that he has provided consultation to the following pharmaceutical companies: Abbott, Acadia, Adamas, Anavex, Astellas, Avanir, Bayer, BMS, Eisai, EnVivo, ExonHit, Janssen, Forest, Genentech, GSK, Lundbeck, Merck, Neurokos, Novartis, Otsuka, Pfizer, Prana, QR Pharma, Sanofi-Aventis, and Takeda.

Pages

Recommended Reading

National Plan to Overcome Alzheimer's Disease Takes Shape
MDedge Family Medicine
Haloperidol Doubles Risk of Death in Institutionalized Elderly
MDedge Family Medicine
Scan That Predicts Alzheimer's Creates Moral Dilemma
MDedge Family Medicine
Continuing Donepezil Appears Best for Some Alzheimer's Patients
MDedge Family Medicine
Asymptomatic Carotid Disease Impairs Cognitive Function
MDedge Family Medicine
Pain Medications Relieve Agitation in Demented Patients
MDedge Family Medicine
Monitoring Antipsychotic Side Effects Infrequent Among Dementia Patients
MDedge Family Medicine
Delirium Due to Medical Cause Often Misdiagnosed as Psychiatric Disorder
MDedge Family Medicine
Single Question Flags Depression in Chronic Pain
MDedge Family Medicine
Diabetes Managed More Tightly in Demented Patients
MDedge Family Medicine